Moderna Inc. plans to produce at least 600 million doses of the company’s Covid-19 vaccine in 2021, up by 100 million doses from the previous forecast, as the United States continues to roll out the vaccine.

VBI Vaccines Inc. said the company expected to begin human testing of two experimental Covid-19 vaccine candidates at the end of the 2020.